Vernalis corporate website

One of the UK's leading development stage pharmaceutical companies, Vernalis takes promising product candidates along a commercially-focused path to market

Vernalis corporate website

Latest News

Tuesday, 17 January 2012

Vernalis and Servier Sign Third Oncology Collaboration

Vernalis plc, Servier announce they have entered into a new three-year joint oncology collaboration focused on the discovery of drugs for a new undisclosed target.

Annual Report 2010Apr 12, 2011

2010 Results

Download our latest financial report...

 

ceoAugust 03, 2011

Interim Results 2011 webcast

Our latest results presentation is available to view via webcast...

 

Attention: open in a new window. PDFPrintE-mail

Share price:  19.25p
Change:  -0.14 (-0.70%)
As at:  27 January 2012 18:15:01
Volume:  40,653
LSE ID:  VER